These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3164710

  • 1. Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells.
    Mulder KM, Brattain MG.
    Int J Cancer; 1988 Jul 15; 42(1):64-70. PubMed ID: 3164710
    [Abstract] [Full Text] [Related]

  • 2. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
    Levine AE, Black B, Brattain MG.
    J Cell Physiol; 1989 Mar 15; 138(3):459-66. PubMed ID: 2925796
    [Abstract] [Full Text] [Related]

  • 3. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
    Mulder KM, Ramey MK, Hoosein NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7120-5. PubMed ID: 3191488
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
    Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG.
    Cancer Res; 1987 Jun 01; 47(11):2950-4. PubMed ID: 3471320
    [Abstract] [Full Text] [Related]

  • 5. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
    Marks ME, Ziober BL, Brattain MG.
    Cancer Res; 1986 Oct 01; 46(10):5248-58. PubMed ID: 3756877
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line.
    Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG.
    Cancer Lett; 1988 Jun 15; 40(2):219-32. PubMed ID: 3164250
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.
    Levine AE, Lewis LR.
    Cancer Lett; 1993 Jan 15; 68(1):33-41. PubMed ID: 8422647
    [Abstract] [Full Text] [Related]

  • 8. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J.
    Cancer Res; 1989 Apr 15; 49(8):2112-7. PubMed ID: 2539253
    [Abstract] [Full Text] [Related]

  • 9. Modulation of c-myc by transforming growth factor-beta in human colon carcinoma cells.
    Mulder KM, Levine AE, Hernandez X, McKnight MK, Brattain DE, Brattain MG.
    Biochem Biophys Res Commun; 1988 Jan 29; 150(2):711-6. PubMed ID: 2893611
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of c-myc in a transformed cell line approaching stationary phase growth in culture.
    Mulder KM, Levine AE, Hinshaw XH.
    Cancer Res; 1989 May 01; 49(9):2320-6. PubMed ID: 2706619
    [Abstract] [Full Text] [Related]

  • 11. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S, Tobon A, Varani J, Brattain MG.
    Cancer Res; 1988 Jul 15; 48(14):4059-64. PubMed ID: 3289738
    [Abstract] [Full Text] [Related]

  • 12. Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines.
    Taylor CW, Kim YS, Childress-Fields KE, Yeoman LC.
    Cancer Lett; 1992 Feb 29; 62(2):95-105. PubMed ID: 1540946
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state.
    Mulder KM.
    Cancer Res; 1991 May 01; 51(9):2256-62. PubMed ID: 2015589
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.
    Mulder KM, Zhong Q, Choi HG, Humphrey LE, Brattain MG.
    Cancer Res; 1990 Dec 01; 50(23):7581-6. PubMed ID: 1701348
    [Abstract] [Full Text] [Related]

  • 16. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME, Coudray AM, Bréant B, Mester J.
    Cancer Res; 1989 Dec 01; 49(23):6566-71. PubMed ID: 2684395
    [Abstract] [Full Text] [Related]

  • 17. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL, Yaswen LR, Tarnuzzer RW, Moldawer LL, Bland KI, Copeland EM, Schultz GS.
    Ann Surg; 1995 Jun 01; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of transforming growth factor beta, N,N-dimethylformamide, and retinoic acid on transformed and nontransformed fibroblasts.
    Hoosein NM, Brattain DE, McKnight MK, Brattain MG.
    Exp Cell Res; 1988 Mar 01; 175(1):125-35. PubMed ID: 3162213
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.